METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.
Topic: Research Applicant Training
Time: Jan 10, 2024 01:00 PM Eastern Time (US and Canada)
Join Zoom Meeting
https://us06web.zoom.us/j/87511986367 pwd=eu5hwCIjUpzYXpYTLEpwqYHoOqHHla.1
Meeting ID: 875 1198 6367
Passcode: 606526
METAvivor Translational Research Award: Up to 2 years, $300,000 award for established investigators.
Application Portal Opens: February 1, 2024
Required Letter of Intent Due: March 11, 2024
Invitations to Submit Full Application Sent: June 2, 2024
Invited Applications Due: August 22, 2024
Announcement of Awardees: December 18, 2024
METAvivor Early Career Investigator Award: Up to 2 years, $200,000 award available to early career applicants (investigators within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started).
Application Portal Opens: January 31, 2024
Required Letter of Intent Due: March 12, 2024
Invitations to Submit Full Application Sent: June 1, 2024
Invited Applications Due: August 21, 2024
Announcement of Awardees: December 18, 2024
METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.
Thank you for your interest and participation.
